Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mandy Jongbloed

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Translational Lung Cancer Research|September 15, 2025
Adjuvant radiotherapy in the era of new peri-operative systemic treatments for surgically resected non-small-cell lung cancer: where do we stand?Francesca R Ogliari, Jarno W J Huijs, Mandy Jongbloed, et al.
JAMA Oncology|September 4, 2025
Current Controversies and Challenges in Non-Oncogene-Addicted Synchronous Oligometastatic Non-Small Cell Lung Cancer: A ReviewMandy Jongbloed, Martina Bortolot, Jonas Willmann, et al.
Current Oncology Reports|January 4, 2024
Measured Steps: Navigating the Path of Oligoprogressive Lung Cancer with Targeted and ImmunotherapiesMandy Jongbloed, Atulya A Khosla, Valentina Bartolomeo, et al.
Infectious Diseases (London, England)|February 22, 2021
Clinical impact of human metapneumovirus infections before and during the COVID-19 pandemicMandy Jongbloed, Wouter T Leijte, Catharina F M Linssen, et al.
Cancers|January 11, 2024
Cachexia and Sarcopenia in Oligometastatic Non-Small Cell Lung Cancer: Making a Potential Curable Disease Incurable?Valentina Bartolomeo, Mandy Jongbloed, Wouter R P H van de Worp, et al.
JTO Clinical and Research Reports|December 30, 2024
Prognostic and Predictive Biomarkers of Oligometastatic NSCLC: New Insights and Clinical ApplicationsMandy Jongbloed, Martina Bortolot, Leonard Wee, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2025
Overall survival in patients with non-small cell lung cancer and leptomeningeal metastases: Data from the Dutch cancer RegistryJarno W J Huijs, Francesca R Ogliari, Ronald A M Damhuis, et al.
JTO Clinical and Research Reports|February 24, 2025
Impact of Immune Checkpoint Inhibitors and Local Radical Treatment on Survival Outcomes in Synchronous Oligometastatic NSCLCMandy Jongbloed, Valentina Bartolomeo, Martina Bortolot, et al.
Lung Cancer (Amsterdam, Netherlands)|December 31, 2025
Effect of treatment sequencing on outcome of patients with non-small cell lung cancer with a synchronous solitary extrathoracic metastasisMandy Jongbloed, Ronald A M Damhuis, Wouter H Van Geffen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 10, 2025
Association of metabolic tumour volume (MTV) and total lesion glycolysis (TLG) with survival in patients with oligometastatic non-small-cell lung cancer treated with immunotherapy: a multicentre retrospective studyFrancesca Rita Ogliari, Mandy Jongbloed, Rianne D W Vaes, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Translational Lung Cancer Research|September 15, 2025
Adjuvant radiotherapy in the era of new peri-operative systemic treatments for surgically resected non-small-cell lung cancer: where do we stand?Francesca R Ogliari, Jarno W J Huijs, Mandy Jongbloed, et al.
JAMA Oncology|September 4, 2025
Current Controversies and Challenges in Non-Oncogene-Addicted Synchronous Oligometastatic Non-Small Cell Lung Cancer: A ReviewMandy Jongbloed, Martina Bortolot, Jonas Willmann, et al.
Current Oncology Reports|January 4, 2024
Measured Steps: Navigating the Path of Oligoprogressive Lung Cancer with Targeted and ImmunotherapiesMandy Jongbloed, Atulya A Khosla, Valentina Bartolomeo, et al.
Infectious Diseases (London, England)|February 22, 2021
Clinical impact of human metapneumovirus infections before and during the COVID-19 pandemicMandy Jongbloed, Wouter T Leijte, Catharina F M Linssen, et al.
Cancers|January 11, 2024
Cachexia and Sarcopenia in Oligometastatic Non-Small Cell Lung Cancer: Making a Potential Curable Disease Incurable?Valentina Bartolomeo, Mandy Jongbloed, Wouter R P H van de Worp, et al.
JTO Clinical and Research Reports|December 30, 2024
Prognostic and Predictive Biomarkers of Oligometastatic NSCLC: New Insights and Clinical ApplicationsMandy Jongbloed, Martina Bortolot, Leonard Wee, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2025
Overall survival in patients with non-small cell lung cancer and leptomeningeal metastases: Data from the Dutch cancer RegistryJarno W J Huijs, Francesca R Ogliari, Ronald A M Damhuis, et al.
JTO Clinical and Research Reports|February 24, 2025
Impact of Immune Checkpoint Inhibitors and Local Radical Treatment on Survival Outcomes in Synchronous Oligometastatic NSCLCMandy Jongbloed, Valentina Bartolomeo, Martina Bortolot, et al.
Lung Cancer (Amsterdam, Netherlands)|December 31, 2025
Effect of treatment sequencing on outcome of patients with non-small cell lung cancer with a synchronous solitary extrathoracic metastasisMandy Jongbloed, Ronald A M Damhuis, Wouter H Van Geffen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 10, 2025
Association of metabolic tumour volume (MTV) and total lesion glycolysis (TLG) with survival in patients with oligometastatic non-small-cell lung cancer treated with immunotherapy: a multicentre retrospective studyFrancesca Rita Ogliari, Mandy Jongbloed, Rianne D W Vaes, et al.
Pageof 2